Kyle Chang

46.3k total citations
27 papers, 825 citations indexed

About

Kyle Chang is a scholar working on Pathology and Forensic Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Kyle Chang has authored 27 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 13 papers in Cancer Research and 11 papers in Molecular Biology. Recurrent topics in Kyle Chang's work include Genetic factors in colorectal cancer (15 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal Cancer Treatments and Studies (4 papers). Kyle Chang is often cited by papers focused on Genetic factors in colorectal cancer (15 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal Cancer Treatments and Studies (4 papers). Kyle Chang collaborates with scholars based in United States, Spain and Australia. Kyle Chang's co-authors include Eduardo Vilar, Steven M. Lipkin, Shuibing Chen, Miguel Crespo, Jenny Xiang, Huanhuan Joyce Chen, Todd Evans, Frederick R. Maxfield, Su‐Yi Tsai and Tuo Zhang and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Kyle Chang

24 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle Chang United States 13 432 353 244 204 138 27 825
Jesús Anampa United States 7 415 1.0× 242 0.7× 230 0.9× 58 0.3× 92 0.7× 14 746
Hans Petter Eikesdal Norway 19 412 1.0× 496 1.4× 292 1.2× 49 0.2× 91 0.7× 41 987
Salo Ooft Netherlands 4 386 0.9× 201 0.6× 186 0.8× 56 0.3× 195 1.4× 5 605
Sharon Glaysher United Kingdom 16 286 0.7× 324 0.9× 112 0.5× 61 0.3× 54 0.4× 30 690
Roberto A. Leon‐Ferre United States 15 447 1.0× 275 0.8× 284 1.2× 93 0.5× 60 0.4× 53 989
Daniel R. Zweitzig United States 8 283 0.7× 360 1.0× 194 0.8× 108 0.5× 71 0.5× 15 636
Julian A. Gingold United States 17 244 0.6× 702 2.0× 293 1.2× 48 0.2× 90 0.7× 60 1.3k
Shane R. Stecklein United States 16 471 1.1× 374 1.1× 356 1.5× 99 0.5× 28 0.2× 52 934
Claudia Felici Italy 15 357 0.8× 534 1.5× 419 1.7× 55 0.3× 94 0.7× 26 1.0k
Andrew N. Stephens Australia 17 342 0.8× 304 0.9× 162 0.7× 89 0.4× 29 0.2× 32 892

Countries citing papers authored by Kyle Chang

Since Specialization
Citations

This map shows the geographic impact of Kyle Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Chang more than expected).

Fields of papers citing papers by Kyle Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Chang. The network helps show where Kyle Chang may publish in the future.

Co-authorship network of co-authors of Kyle Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Chang. A scholar is included among the top collaborators of Kyle Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Chang. Kyle Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quandt, Zoe, Sean Gordon, Kyle Chang, et al.. (2025). Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study. Cancer Research Communications. 5(8). 1384–1395.
2.
Raghav, Kanwal, Lianchun Xiao, Courtney Lewis, et al.. (2024). A randomized study evaluating tailoring of advanced/metastatic colorectal cancer (mCRC) therapy using circulating tumor DNA (ctDNA): TACT-D.. Journal of Clinical Oncology. 42(17_suppl). LBA3557–LBA3557.
3.
Düzağaç, Fahriye, Nan Deng, Laura Reyes-Uribe, et al.. (2024). Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention. Gastroenterology. 166(5). 787–801.e11. 17 indexed citations
4.
Chen, Sai, Katie Quinn, Che-Yu Lee, et al.. (2023). Abstract 3123: A method for quantifying circulating tumor DNA level and molecular response using methylome sequencing. Cancer Research. 83(7_Supplement). 3123–3123. 4 indexed citations
5.
Lee, Jii Bum, Hyung Soon Park, Su Jin Choi, et al.. (2022). Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy. Therapeutic Advances in Medical Oncology. 14. 4287553793–4287553793. 3 indexed citations
6.
Chang, Kyle, Florencia McAllister, & Eduardo Vilar. (2022). Transcriptomic-Assisted Immune and Neoantigen Profiling in Premalignancy. Methods in molecular biology. 2435. 95–105. 3 indexed citations
7.
Borràs, Ester, Wenhui Wu, Kyle Chang, et al.. (2021). Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Cancer Prevention Research. 14(9). 851–862. 10 indexed citations
8.
Semaan, Alexander, Vincent Bernard, Jaewon J. Lee, et al.. (2020). Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples. Clinical Cancer Research. 27(4). 1082–1093. 20 indexed citations
9.
D’Anna, Laura Hoyt, et al.. (2020). Marijuana Use and Sexual Risk Behavior Among Young Black Men Who Have Sex with Men in California. Journal of Racial and Ethnic Health Disparities. 8(6). 1522–1532. 7 indexed citations
10.
Chang, Kyle, Smruthy Sivakumar, Yao Yu, et al.. (2019). Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer. Nature Biotechnology. 38(1). 90–96. 30 indexed citations
11.
Sandoval, Imelda T., Kyle Chang, Laura Reyes-Uribe, et al.. (2019). Functional characterization of CNOT3 variants identified in familial adenomatous polyposis adenomas. Oncotarget. 10(39). 3939–3951. 3 indexed citations
12.
You, Y. Nancy, Ester Borràs, Kyle Chang, et al.. (2019). Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Diseases of the Colon & Rectum. 62(4). 429–437. 19 indexed citations
13.
Chang, Kyle, Jason Willis, Joke Reumers, et al.. (2018). Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. Annals of Oncology. 29(10). 2061–2067. 38 indexed citations
14.
Borràs, Ester, Kyle Chang, Mala Pande, et al.. (2017). In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. Cancer Prevention Research. 10(10). 580–587. 12 indexed citations
15.
Crespo, Miguel, Eduardo Vilar, Su‐Yi Tsai, et al.. (2017). Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nature Medicine. 23(7). 878–884. 293 indexed citations
16.
Boutin, Adam T., Wenting Liao, Soyoon Hwang, et al.. (2017). Oncogenic Kras drives invasion and maintains metastases in colorectal cancer. Genes & Development. 31(4). 370–382. 137 indexed citations
17.
Borràs, Ester, F. Anthony San Lucas, Kyle Chang, et al.. (2016). Genomic Landscape of Colorectal Mucosa and Adenomas. Cancer Prevention Research. 9(6). 417–427. 61 indexed citations
18.
Zhang, Wenqian, Kyle Chang, Wan Mohaiza Dashwood, et al.. (2016). Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam. International Journal of Cancer. 140(2). 460–468. 18 indexed citations
19.
Cheung, Hannah, F Anthony San Lucas, Stephanie C. Hicks, et al.. (2012). An S/T-Q cluster domain census unveils new putative targets under Tel1/Mec1 control. BMC Genomics. 13(1). 664–664. 15 indexed citations
20.
Butte, Nancy F., V. Saroja Voruganti, Shelley A. Cole, et al.. (2011). Resequencing ofIRS2reveals rare variants for obesity but not fasting glucose homeostasis in Hispanic children. Physiological Genomics. 43(18). 1029–1037. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesús Anampa Breakdown of academic impact, for papers by Hans Petter Eikesdal Breakdown of academic impact, for papers by Salo Ooft Breakdown of academic impact, for papers by Sharon Glaysher Breakdown of academic impact, for papers by Roberto A. Leon‐Ferre Breakdown of academic impact, for papers by Daniel R. Zweitzig Breakdown of academic impact, for papers by Julian A. Gingold Breakdown of academic impact, for papers by Shane R. Stecklein Breakdown of academic impact, for papers by Claudia Felici Breakdown of academic impact, for papers by Andrew N. Stephens
Rankless by CCL
2026